Interview with Urologic Oncologist About BCG & COVID-19
BladderCancer.net writer and moderator, Renata, interviews Dr. Terry Friedlander, a genitourinary medical oncologist at the University of California, San Francisco (UCSF) who specializes in bladder and prostate cancers. During their conversation, Dr. Friedlander gives us an overview and shares his perspective of how COVID-19 is impacting people with bladder cancer in San Francisco at UCSF as of April 17, 2020, the date of this interview. This part of their conversation covers BCG for people with non-invasive bladder cancer in the context of COVID-19.
The COVID-19 crisis in the US is a fluid and rapidly changing situation. For more information, see Self-Care in Uncertain Times.
How are you raising bladder cancer awareness this month?